|
MICROMATRICES ASSOCIATES LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
MINA (HOLDINGS) LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- February 2026
- April 2026
- May 2026
|
|
MIROBIO LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
MITOTYPE PRECISION LABS LIMI TED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
MODERNA BIOTECH MANUFACTURIN G UK LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
MOLECULAR DEVICES (UK) LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- April 2026
- May 2026
|
|
MOLEKULA LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
MYRICX PHARMA LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
NEW ENGLAND BIOLABS (UK) LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- March 2026
- April 2026
- May 2026
- June 2026
|
|
NEWCELLS BIOTECH LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
|
|
NEXUS BIOQUEST LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- April 2026
|
|
NHS BLOOD AND TRANSPLANT
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- May 2026
|
|
NOVA BIOMEDICAL CORPORATION
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
NOVARTIS PHARMA AG
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- February 2026
- March 2026
- April 2026
- May 2026
- June 2026
|
|
NOVARTIS PHARMACEUTICALS UK LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- February 2026
- April 2026
- May 2026
- June 2026
|
|
NXERA PHARMA UK LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- February 2026
- March 2026
- June 2026
|
|
O2H LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
ORIBIOTECH LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
ORION PHARMA (UK) LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
ORTHO-CLINICAL DIAGNOSTICS
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
OXFORD BIOMEDICA PLC
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- March 2026
- April 2026
- May 2026
- June 2026
|
|
OXFORD BIOSYSTEMS LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
OXFORD NANOPORE TECHNOLOGIES PLC
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- March 2026
- April 2026
- May 2026
|
|
OXUNIPRINT LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- February 2026
- May 2026
- June 2026
|
|
PERCEPTIVE ECLINICAL LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
PFIZER INC
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
PHARMANUTRA LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
PHARMARON BIOLOGICS (UK) LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
PICOLAB TECHNOLOGIES LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
PROMATIX BIOSCIENCES LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
PROMEGA LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- March 2026
- April 2026
- May 2026
- June 2026
|
|
PROTHERICS UK LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
QUEEN MARY UNIVERSITY OF LONDON
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- March 2026
- April 2026
- May 2026
- June 2026
|
|
QUELL THERAPEUTICS LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
QUOTIENT THERAPEUTICS LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- May 2026
- June 2026
|
|
RANDOX LABORATORIES LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
RELATION THERAPEUTICS LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- February 2026
- March 2026
- May 2026
|
|
RENEURON LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
REPROCELL EUROPE LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
RESOLUTION THERAPEUTICS LIMI TED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
RINRI THERAPEUTICS LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
ROSLIN CELL THERAPIES LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
ROSLIN TECHNOLOGIES LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
RXCELERATE LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
SAFI BIOSOLUTIONS LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
SAMSUNG BIOEPIS CO LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- March 2026
- April 2026
- May 2026
- June 2026
|
|
SARTORIUS STEDIM BIOOUTSOURCE LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- June 2026
|
|
SCANCELL LIMITED
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
SCIENTIFIC LABORATORY SUPPLIES LT D
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
|
|
SERA LABORATORIES INTERNATION AL LTD
|
Commodity code: 30 02 59 0030025900
|
Cell cultures, whether or not modified (excl. cell therapy products) |
- January 2026
- February 2026
- March 2026
- June 2026
|